Mishandling of the Therapeutic Peptide Glucagon Generates Cytotoxic Amyloidogenic Fibrils

Author： Onoue Satomi   Ohshima Keiichi   Debari Kazuhiro   Koh Keitatsu   Shioda Seiji   Iwasa Sumiko   Kashimoto Kazuhisa   Yajima Takehiko  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.21, Iss.7, 2004-07, pp. : 1274-1283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease

By Hornby Pamela J   Moore Beverley A  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 637-646

Informa Healthcare

Access to resources Recommend Favorite

Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives

By Meier J.J.   Gallwitz B.   Schmidt W.E.   Nauck M.A.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 269-279

Elsevier

Access to resources Recommend Favorite

Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs

By Mentlein Rolf  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 57-64

Informa Healthcare

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus

By  

Current Medicinal Chemistry, Vol. 10, Iss. 22, 2003-11 ,pp. : 2471-2483

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Glucagon-Like Peptide-1-Based Pharmaceuticals as Therapeutic Agents for the Treatment of Diabetes

By  

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1399-1412

Bentham Science Publishers

Access to resources Recommend Favorite